Healthcare Analytics Market Projected to Gross $11B; Health Tech Startup Incubators Launch in NYC; Access to Medicines Index Says Major Drug Makers Send More Medicine to the Poor - Health Minute for December 12, 2012

Primary tabs

Healthcare Analytics Market Projected to Gross $11B; Health Tech Startup Incubators Launch in NYC; Access to Medicines Index Says Major Drug Makers Send More Medicine to the Poor - Health Minute for December 12, 2012

tweet me:
#Healthcare Analytics Market to Gross $11B, http://3bl.me/tm5vfs #HealthTech Incubators Launch in NYC, Major drug makers send more to poor

Multimedia from this Release

Wednesday, December 12, 2012 - 1:30pm

CONTENT: Press Release

The healthcare analytics market, currently estimated to be worth $3.7 billion, could be worth almost $11 billion by 2017. In the U.S., the market is scoring double-digit annual growth. Healthcare analytics develops tools and systems to plan and analyze medical data that can be applied to healthcare practices., such as predicting and improving medical outcomes. Big data, where vast quantities of information can be cheaply stored and analyzed, and mobile technology are driving the growth, says the report, published by Markets and Markets.

Fashion, media, finance—New York City’s list of major business sectors is adding health tech to the list with the launching of several incubator programs that provide funding, mentorship, and connections. Startup Health, Blueprint Health and the New York Digital Health Accelerator began their first classes of health tech startups earlier this year. Now, Bio and Health Tech Entrepreneurship Lab is accepting applications for its first class of entrepreneurs. New York is joining San Francisco and Chicago to create hubs to support innovation in health tech-driven medical practices, from treatment to record keeping.

The Access to Medicines Index, which tracks the top 20 drug makers’ efforts to make their medicines available and affordable in poor countries, has recorded an improvement in the past two years. This change reflects both commercial self-interest and a concern for reputation, according to the Index. The nonprofit group that issues the Index, finds that some big pharmaceutical companies, led by Johnson & Johnson, are stepping up their efforts. The Index also noted that only four companies—Sanofi, Merck & Co, GlaxoSmithKline, and Eisai—provided evidence to show that clinical trials outsourced to overseas countries met safety and ethical standards.

For more information on these and other stories, go to 3blmedia.com

Video Source: Healthcare Analytics Market Projected to Gross $11B; Health Tech Startup Incubators Launch in NYC; Access to Medicines Index Says Major Drug Makers Send More Medicine to the Poor

Keywords: 3bl Media | Access to Medicines Index | Blueprint Health | Eisai | GlaxoSmithKline | Health | Health Minute | Markets and Markets | Merck & Co | New York Digital Health Accelerator | Sanofi

CONTENT: Press Release

parse.ly